If you’ve been struggling with chronic fatigue, brain fog, sinus issues, asthma, or unexplained inflammation, mold exposure may be part of the picture. Water-damaged buildings are increasingly recognized as contributors to respiratory disease and, in some individuals, persistent multi-system symptoms.
In this article, we’ll explore:
- How chronic mold exposure happens
- Common and long-term symptoms
- Who is most at risk
- A clinical comparison of the Shoemaker (CIRS) protocol and the Campbell mycotoxin protocol
What Is Chronic Mold Exposure?
Mold is a naturally occurring fungus found both indoors and outdoors. Problems develop when moisture intrusion (roof leaks, plumbing leaks, flooding, humidity >75%) allows mold to proliferate inside buildings.
Damp indoor spaces are associated with:
- Upper respiratory symptoms
- Chronic sinus congestion
- Cough and wheezing
- Asthma exacerbation
- Increased risk of new-onset asthma in some populations [1]
Certain individuals appear more sensitive to prolonged exposure, especially those with asthma, allergies, immune dysregulation, or genetic susceptibility.
How Mold Exposure Occurs
Exposure most commonly happens through:
- Inhalation of spores and fragments
- Contact with contaminated dust
- Living or working in water-damaged buildings
After floods or hurricanes, mold growth can become extensive within 48 hours, increasing exposure risk [2].
Importantly, mold-related illness is most clearly linked to allergic and respiratory conditions. The role of inhaled mycotoxins in causing systemic toxicity remains debated in conventional toxicology literature [3].
Symptoms of Chronic Mold Exposure
1. Respiratory Symptoms
- Chronic sinus congestion
- Post-nasal drip
- Chronic cough
- Shortness of breath
- Asthma flares
Indoor dampness and fungal exposure are associated with asthma morbidity and symptom worsening [1].
2. Immune & Inflammatory Symptoms
- Persistent nasal inflammation
- Recurrent sinus infections
- Hypersensitivity pneumonitis (rare but serious)
3. Neurological & Systemic Symptoms (Reported Clinically)
Some patients report:
- Brain fog
- Memory difficulty
- Fatigue
- Headaches
- Mood changes
- Temperature dysregulation
Severe indoor-air-related symptom syndromes can lead to meaningful functional impairment in a subset of patients [4].
Long-Term Effects of Mold Exposure
For most individuals, removal from exposure leads to improvement. However, potential long-term issues may include:
- Chronic asthma
- Persistent airway hyperreactivity
- Ongoing inflammatory symptoms
- Quality-of-life impairment
The key intervention is always identifying and correcting the environmental source.
Shoemaker vs. Campbell Mold Treatment Protocols
In integrative and functional medicine, two primary frameworks are often used to address chronic mold-related illness.
The Shoemaker Protocol (CIRS Model)
Developed by: Dr. Ritchie Shoemaker
Focus: Chronic Inflammatory Response Syndrome (CIRS)
Core Theory
Genetically susceptible individuals develop persistent innate immune activation after exposure to water-damaged buildings.
Diagnostic Approach
Common labs may include:
- HLA-DR genetic typing
- C4a
- TGF-β1
- MMP-9
- VEGF
- ADH/osmolality
- MARCoNS nasal culture
- Visual Contrast Sensitivity (VCS)
Treatment Sequence
The Shoemaker protocol is highly structured:
- Remove from exposure
- Cholestyramine (binder)
- Treat MARCoNS (if present)
- Correct inflammatory markers
- VIP nasal spray (final phase)
Pros
- Structured, stepwise approach
- Biomarker tracking
Considerations
- Complex lab work
- Strict sequencing
- Insurance limitations
The Campbell Mycotoxin Protocol
Focus: Reducing fungal colonization and supporting detoxification pathways
This approach differs significantly from Shoemaker’s model.
Core Strategy
- Prescription antifungal therapy
- Used when fungal colonization is suspected
- Targets potential internal fungal overgrowth
- Nine targeted vitamins to support detoxification pathways
These may include nutrients that support:
- Methylation
- Glutathione production
- Liver phase I and II detoxification
- Mitochondrial support
- No binders are routinely recommended
Unlike the Shoemaker protocol, the Campbell model does not rely on cholestyramine or other toxin binders.
Philosophical Differences
| Shoemaker | Campbell |
| Focuses on immune dysregulation | Focuses on fungal burden & detox support |
| Uses bile acid binders | Uses antifungal prescriptions |
| Structured lab algorithm | Clinical + detox-focused |
| VIP nasal spray final step | Nutrient repletion emphasis |
Clinical Considerations
Prescription antifungals must be used carefully and monitored appropriately, as systemic antifungal therapy carries potential side effects and drug interaction considerations in other contexts of fungal treatment [5].
Which Mold Protocol Is Right?
The correct approach depends on:
- Patient symptom pattern
- Environmental findings
- Lab markers
- Medication tolerance
- Overall inflammatory burden
Regardless of protocol, environmental remediation is non-negotiable. Ongoing exposure will undermine any treatment plan.
Key Takeaways
- Mold exposure is strongly linked to respiratory and allergic disease.
- A subset of patients develop persistent, multi-system symptoms.
- Removal from exposure is foundational.
- Shoemaker and Campbell protocols differ significantly in philosophy and treatment tools.
- Personalized evaluation is essential.
If you suspect mold exposure is impacting your health, a comprehensive evaluation can help determine next steps.
Sources:
- Exposure and health effects of fungi on humans. The Journal of Allergy and Clinical Immunology: In Practice, 2016
- Mold prevention strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR: Recommendations and Reports, 2006
- ACMT position statement: medical toxicology considerations in the diagnosis and treatment of patients with concerns about mold-related inhalation exposures. ACMT, 2025
- The continuum of severity of functional impairment due to indoor air symptoms: prevalence and determinants. Journal of Occupational and Environmental Medicine, 2023
- Duration of antifungal treatment in mold infection: when is enough?. Current Opinion in Infectious Diseases, 2023
